
Rodger Tiedemann
Dr. Rodger Tiedemann is a haematologist at Auckland Hospital and an associate professor of medicine at the University of Auckland, who advocates for the funding of daratumumab, a drug that significantly improves survival rates for patients with multiple myeloma and AL amyloidosis, highlighting New Zealand's lag in providing such essential treatments.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Dr Rodger Tiedemann says drugs like lenalidomide can extend life by 5-10 years.
8
New Zealand:
Dr. Rodger Tiedemann stated that patients with multiple myeloma lived longer on daratumumab.
7